Organoids Evolve from Academic Marvel to Industrial Tool
This article explores the growing landscape of organoid technology and its transformative impact on healthcare research and drug development. From automation and OOC technologies through tonsil cells and tons of organoids, these structures are just getting started as commercial-scale tools for healthcare research and the development of new treatments.
Featuring industry voices from Corning Life Sciences, Charles River Laboratories, and Emulate, the story also highlights Molecular Devices' advancements in large-scale organoid production and our goal of industrializing organoids to expand their use beyond academia into high-throughput settings.